>The study determines the efficiency of India'/> Efficiency and Its Determinants: Panel Data Evidence from the Indian Pharmaceutical Industry
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Margin: The Journal of Applied Economic Research >Efficiency and Its Determinants: Panel Data Evidence from the Indian Pharmaceutical Industry
【24h】

Efficiency and Its Determinants: Panel Data Evidence from the Indian Pharmaceutical Industry

机译：效率及其决定因素：来自印度制药业的面板数据证据

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

>The study determines the efficiency of Indian pharmaceutical firms and its determinants in the pre- and post-product patent regime. Overall inefficiency in the industry is higher due to the inefficient conversion of inputs into output rather than through scale inefficiency. The study finds that the Product Patent Act has a negative impact on efficiency. Ownership, capital imports intensity and size variables are positively related with efficiency scores whereas age, time dummy and size square variables are inversely related. The study supports the finding that with an increase in mergers and acquisitions, a movement towards diversifying operations, the use of advanced imported foreign technology, investment in fixed assets and judicious allocation of resources for marketing activities could improve firm performance. For future policy implications, the small firms may either merge into bigger entities or manufacture pharmaceutical products for other companies, so as to raise operational scale and improve capacity utilisation.>JEL Classification:C02, C61, D2, L65
机译： >该研究确定了印度制药公司及其产品售前和售后专利制度的效率。该行业的整体效率低下是由于投入到产出的效率低下而不是规模效率低下所致。研究发现，《产品专利法》对效率有负面影响。所有权，资本进口强度和规模变量与效率得分呈正相关，而年龄，时间假人和规模平方变量呈负相关。该研究支持以下发现：随着并购的增加，朝着多元化经营，使用先进的进口国外技术，对固定资产进行投资以及明智地分配用于营销活动的资源，可以改善公司业绩。对于将来的政策影响，小公司可以合并成更大的实体，也可以为其他公司制造药品，以提高运营规模并提高产能利用率。 > JEL分类： C02，C61，D2，L65

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号